The Journal of Immunology, Vol 158, Issue 3 1157-1164, Copyright © 1997 by American Association of Immunologists

ARTICLES

Conformational transitions in CD4 due to complexation with HIV envelope glycoprotein gp120

G Denisova, D Raviv, I Mondor, QJ Sattentau and JM Gershoni
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel.

The binding of the surface envelope glycoprotein gp120 to its receptor, CD4, has been well characterized and is the primary basis for the cell tropism of HIV. In this study, the interaction between recombinant soluble CD4 and native membrane-associated CD4 with gp120 is probed by the use of mAbs. Complexation of gp120 with both forms of CD4 induces conformational epitopes that can be defined with specific mAbs. CG1, CG7, and CG8 are three novel mAbs that have a distinct preference for CD4 complexed over noncomplexed with gp120. The epitopes of these unique mAbs were mapped by cross-inhibition with previously characterized mAbs to a region encompassing the CDR2 and CDR3 loops in domain 1 of CD4. Systematic analysis of CG mAbs binding to CD4 and CD4/gp120 complex delineates a region in the D1 domain of CD4 that undergoes conformational rearrangements upon gp120 binding to its receptor.

This article has been cited by other articles:

				Z. Si, M. Cayabyab, and J. Sodroski Envelope Glycoprotein Determinants of Neutralization Resistance in a Simian-Human Immunodeficiency Virus (SHIV-HXBc2P 3.2) Derived by Passage in Monkeys J. Virol., May 1, 2001; 75(9): 4208 - 4218. [Abstract] [Full Text]

				P. Kolchinsky, E. Kiprilov, P. Bartley, R. Rubinstein, and J. Sodroski Loss of a Single N-Linked Glycan Allows CD4-Independent Human Immunodeficiency Virus Type 1 Infection by Altering the Position of the gp120 V1/V2 Variable Loops J. Virol., April 1, 2001; 75(7): 3435 - 3443. [Abstract] [Full Text]

				P. Kolchinsky, E. Kiprilov, and J. Sodroski Increased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants J. Virol., March 1, 2001; 75(5): 2041 - 2050. [Abstract] [Full Text]

				P. Kolchinsky, T. Mirzabekov, M. Farzan, E. Kiprilov, M. Cayabyab, L. J. Mooney, H. Choe, and J. Sodroski Adaptation of a CCR5-Using, Primary Human Immunodeficiency Virus Type 1 Isolate for CD4-Independent Replication J. Virol., October 1, 1999; 73(10): 8120 - 8126. [Abstract] [Full Text] [PDF]

				M. Flint, C. Maidens, L. D. Loomis-Price, C. Shotton, J. Dubuisson, P. Monk, A. Higginbottom, S. Levy, and J. A. McKeating Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81 J. Virol., August 1, 1999; 73(8): 6235 - 6244. [Abstract] [Full Text]

				X. Xiao, L. Wu, T. S. Stantchev, Y.-R. Feng, S. Ugolini, H. Chen, Z. Shen, J. L. Riley, C. C. Broder, Q. J. Sattentau, et al. Constitutive cell surface association between CD4 and CCR5 PNAS, June 22, 1999; 96(13): 7496 - 7501. [Abstract] [Full Text] [PDF]

				B. D. Zelus, D. R. Wessner, R. K. Williams, M. N. Pensiero, F. T. Phibbs, M. deSouza, G. S. Dveksler, and K. V. Holmes Purified, Soluble Recombinant Mouse Hepatitis Virus Receptor, Bgp1b, and Bgp2 Murine Coronavirus Receptors Differ in Mouse Hepatitis Virus Binding and Neutralizing Activities J. Virol., September 1, 1998; 72(9): 7237 - 7244. [Abstract] [Full Text] [PDF]

				N. Sullivan, Y. Sun, Q. Sattentau, M. Thali, D. Wu, G. Denisova, J. Gershoni, J. Robinson, J. Moore, and J. Sodroski CD4-Induced Conformational Changes in the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein: Consequences for Virus Entry and Neutralization J. Virol., June 1, 1998; 72(6): 4694 - 4703. [Abstract] [Full Text] [PDF]